about
Mechanisms of fibrin polymerization and clinical implicationsModels for thrombin generation and risk of diseaseBleeding related to disturbed fibrinolysisTACTIC: Trans-Agency Consortium for Trauma-Induced CoagulopathyProcoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.Synthetic Strategies for Engineering Intravenous Hemostats.Solulin increases clot stability in whole blood from humans and dogs with hemophilia.Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiencyThe influence of prophylactic factor VIII in severe haemophilia A.Clinical and imaging analysis of subclinical hemophilia combined with coxarthrosis: case report and literature review.Thrombin generation in hemorrhage control and vascular occlusion.Modeling thrombin generation: plasma composition based approach.Can the phenotype of inherited fibrinogen disorders be predicted?Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin.Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation.Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause.Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.A hybrid-system model of the coagulation cascade: simulation, sensitivity, and validation.FXIII: mechanisms of action in the treatment of hemophilia A.Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A.Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients.In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus
P2860
Q26865281-EFE17EFF-0EB8-43C1-8D60-94A7089AA6BFQ27013171-90047420-F3C1-4ED7-97FF-5B761D4C0627Q28070127-A8373026-4AE4-48F9-BA49-827F45C20A08Q28083939-D3A93E79-D964-4595-A53A-B35E23E81DF9Q35690807-894C6C7F-4AD1-45D3-8AC0-995AE60D0A78Q35788435-9B889179-A5B7-44B8-B836-26D2CAEB8D5BQ35858739-1BC11DDA-D671-4454-B4B6-EA3A380AC277Q35885322-BAFDA3D7-BBDA-4B59-904D-29264CDBA48FQ36163331-593CF0FE-06E7-4095-AB53-EDF643C9F468Q37059445-66EEF67A-A498-497B-B9BF-97CA678DF409Q37186732-4933E253-E1E4-4A1D-9575-C5318F3D9D1EQ37463554-8DB5E038-5273-4618-8D26-C5D8AE2151FEQ37900072-A0AD8903-8A3F-4B56-8623-F6DD4979D250Q38161459-CBD8B0D3-4977-4374-A75E-940225088905Q38862956-C42FC83D-073C-411E-8B1B-CC32F8CC3DEEQ39117235-1611FF0B-2F73-4C68-9585-6D0875A79D37Q40447349-73E92E3D-26FD-4910-A3DD-745D5523423CQ40942451-772DF1A9-4CA4-4A98-84F5-1CAAE7C6E1ACQ42360054-6A956B1A-0059-4881-8013-72529CB5CAC8Q44514782-EA8CDF65-BEA5-4940-B3DE-1DC8201D009DQ44950012-4B606C5E-4445-436D-95D7-5043C1979883Q45851000-9314D39C-0840-4E2E-9798-F03FA06809EBQ45857306-5FFBE0E5-0703-472A-A4B4-EE40EFE04825Q45859215-24C434DA-AC27-4B4A-92EE-9EAA0D9681EDQ45865620-D93350AC-E21C-4430-8174-EB1C7AB1F409Q45867938-A92C18FB-0D81-4CA5-8B17-772D12C001C4Q45873682-064B7D9C-1A31-47B0-9E1C-561FC0BF99D9Q48269941-10D1B650-D64E-4493-B261-1E422DFE88D4Q57822378-5C9760B9-6BB4-4CBD-B4D2-86AA26D9FD32
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Discordant fibrin formation in hemophilia.
@ast
Discordant fibrin formation in hemophilia.
@en
type
label
Discordant fibrin formation in hemophilia.
@ast
Discordant fibrin formation in hemophilia.
@en
prefLabel
Discordant fibrin formation in hemophilia.
@ast
Discordant fibrin formation in hemophilia.
@en
P2093
P2860
P1476
Discordant fibrin formation in hemophilia.
@en
P2093
K E Brummel-Ziedins
R F Branda
P2860
P304
P356
10.1111/J.1538-7836.2009.03306.X
P577
2009-01-28T00:00:00Z